Showing results (101-110 of 356) with videos related to
Sort By:
Pageof 36
Drug Safety|March 1, 1991
Quality of life as a therapeutic end-point. An analysis of therapeutic trials in hypertensionN K Hollenberg, M Testa, G H WilliamsJournal of Cardiovascular Pharmacology|January 1, 1991
Constrictive effect of serotonin on visible renal arteries: a pharmacoangiographic study in anesthetized dogsJ L Blackshear, C Orlandi, N K HollenbergMicrovascular Research|July 1, 1986
Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2 receptorC Orlandi, J L Blackshear, N K HollenbergInvestigative Radiology|March 1, 1986
Serotonin-induced visualization of the popliteal lymph node by angiography. A unique microvascular response to serotoninC Orlandi, J L Blackshear, N K HollenbergJournal of Cardiovascular Pharmacology|August 1, 1990
Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: a coded, placebo-controlled animal studyI Repa, J D Garnic, N K HollenbergKidney International|September 1, 1986
Serotonin and the renal blood supply: role of prostaglandins and the 5HT-2 receptorJ L Blackshear, C Orlandi, N K HollenbergHypertension (Dallas, Tex. : 1979)|May 1, 1983
Increase in collateral arterial endothelial cell proliferation induced by captopril after renal artery stenosis in the ratT Odori, A Paskins-Hurlburt, N K HollenbergEndocrine Research|January 1, 1992
Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockadeM S Gordon, G H Williams, N K HollenbergArchives of Internal Medicine|April 28, 1999
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of lifeR B Anderson, N K Hollenberg, G H WilliamsAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1987
Renal abnormalities in nonmodulating essential hypertensionG H Williams, T J Moore, N K HollenbergPageof 36